01:16 PM EDT, 03/13/2020 (MT Newswires) — Gilead Sciences’ (GILD) remdesivir is said to have a positive effect in American cruise passengers who were treated for COVID-19 in Japan, the Wall Street Journal reported on Friday, citing a doctor sent by the US government to Tokyo.
National Institutes of Health assistant surgeon general and lung specialist Richard Childs said that remdesivir was administered to the 14 Americans who contracted the new coronavirus on the Diamond Princess cruise ship.
According to Childs, the 14 passengers, who had an average age of 75 years old, were critically ill. “Many of them were probably going to die in a short amount of time, and two weeks later nobody has died and more than half of them have recovered. It’s just absolutely amazing,” he said, though adding that it will take a while to determine the drug’s impact.
Gilead and independent groups are currently testing remdesivir in the US and Asia, but there remain no available large-scale results.
Can u post the article?
Triple wrote:
“01:16 PM EDT, 03/13/2020 (MT Newswires) Gilead Sciences (GILD) remdesivir is said to have a positive effect in American cruise passengers who were treated for COVID-19 in Japan, the Wall Street Journal reported on Friday, citing a doctor sent by the US government to Tokyo.
National Institutes of Health assistant surgeon general and lung specialist Richard Childs said that remdesivir was administered to the 14 Americans who contracted the new coronavirus on the Diamond Princess cruise ship.
According to Childs, the 14 passengers, who had an average age of 75 years old, were critically ill. Many of them were probably going to die in a short amount of time, and two weeks later nobody has died and more than half of them have recovered. Its just absolutely amazing, he said, though adding that it will take a while to determine the drugs impact.
Gilead and independent groups are currently testing remdesivir in the US and Asia, but there remain no available large-scale results.”
Excellent news!!!